Canada’s cannabis retail market is expanding through consolidation rather than new store openings. The trend highlights how mature legal markets reward scale, efficiency, and disciplined retail strategy.

Another discounted asset sale signals accelerating consolidation in California’s cannabis market. Distressed operators are exiting as capitalized buyers position for long-term efficiency and scale.

Hemp-derived THC has grown into a major parallel market competing with regulated cannabis. A potential federal crackdown could reshape farming, supply chains, and push consumer demand back toward licensed cannabis in 2026.

Wholesale cannabis pricing remains the clearest signal of margin pressure and market survivability. Spot price and forward curve data offer critical insight for cultivators, manufacturers, and brands navigating a disciplined market.

New York’s legal cannabis market surged in 2025, with dispensaries more than doubling and sales surpassing $2.5 billion. The growth highlights strong consumer demand and positions New York as one of the fastest-growing major cannabis markets in the country.

Canada’s cannabis industry is tracking toward a ten billion dollar annual GDP contribution as the market matures. Enforcement and market structure are now shaping outcomes more than rapid expansion, offering lessons for other jurisdictions.

Federal rescheduling improves the outlook for cannabis, but it does not automatically unlock growth. Real scale will come from disciplined operations, capital readiness, and risk management, not policy headlines alone.

Recent wholesale cannabis pricing data highlights continued margin pressure, shifting supply dynamics, and cautious contracting behavior. The spot index offers real time insight into market health and operator risk.

Behind federal rescheduling headlines, U.S. cannabis markets are still experiencing license contraction and consolidation. Operators are shifting focus toward efficiency and long-term sustainability as the industry matures.

Cannabis stocks saw sharp swings after federal rescheduling became official, reflecting how investor sentiment continues to drive short term market behavior. The volatility highlights the gap between policy progress and immediate financial impact.

Texas Original has opened a new 75,000 square foot medical cannabis production campus, significantly expanding cultivation, processing, testing, and distribution. The move signals serious commercial scaling in Texas following expanded patient eligibility under House Bill 46.

Virginia has revived its plan to build an adult use cannabis retail system, with a new draft framework outlining a potential launch in fall 2026. The proposal offers structure for licensing, zoning, safety, and compliance, signaling that real progress is finally underway.

Cronos has announced plans to acquire CanAdelaar B V in the Netherlands, giving the company a strategic foothold in the European cannabis market. The move reflects a growing trend of North American operators pursuing global expansion as international programs evolve.

Wana Brands, one of the leading U.S. edibles companies, has launched THC gummies in Zürich through Switzerland’s cannabis pilot program. The expansion highlights how major cannabis brands are eyeing global markets as new international opportunities emerge.

Trulieve has received conditional approval to cultivate, manufacture, and distribute medical cannabis in Texas — a major sign of the state’s expanding medical program. The move positions Texas for broader access, more competition, and a more sophisticated medical cannabis marketplace.

A new study found that Medicaid recipients living near multiple cannabis shops face higher rates of cannabis-use disorder and related hospitalizations. The research underscores the need for strong compliance, responsible retail practices, and community-driven education as the industry grows.

Virginia’s cannabis commission is preparing to unveil a long-awaited plan for adult-use retail, ending the gap between legalization and legal sales. The proposal eliminates local opt-outs, prioritizes small businesses, and reinvests revenue into communities most harmed by prohibition.

Wisconsin hemp growers and processors are scrambling after federal legislation quietly banned many hemp-derived THC products. The move threatens major revenue streams and pushes the state’s hemp industry into emergency adaptation mode.

A new federal amendment will ban hemp-derived THC products exceeding 0.4 mg THC per container, effectively eliminating the intoxicating hemp category. The rule will reshape the $28 billion hemp-THC industry and force businesses to prepare for major operational changes.

New York’s average cannabis price dropped from $38.61 to $32.15 as licensed store openings and expanded product selection increased competition. This decline shows the market is maturing — but it also raises new challenges for operators navigating shrinking margins and rising compliance pressure.